This study looked at a form of breathing exercise called inspiratory muscle strength training (IMST) and its role in reducing blood pressure (BP). It found IMST resulted in a reduction in systolic blood pressure (SBP).

This study compared acupuncture with anti-depressant medications for the treatment of depression in patients who have had a stroke. It found that post-stroke depression was less severe 3-8 weeks after acupuncture compared to anti-depressant medication.

This review aimed to compare the benefits and risks associated with targeted therapy (TT) and chemoimmunotherapy (CIT) as frontline treatments for chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). 

This study looked at how flow cytometry (FC) measurements predicted outcomes for patients with multiple myeloma (MM). It found that patients who had no traces of minimal residual disease (MRD) by FC had better outcomes.

This study evaluated the impact of idelalisib (Zydelig) interruption or dose reductions on clinical outcomes in patients with relapsed/refractory (r/r) indolent (painless) non-Hodgkin lymphoma (iNHL) and chronic lymphocytic leukemia (CLL). This study showed that stopping idelalisib and reducing the dose due to side effects was associated with improved outcomes in these patients. 

This study investigated the duration, level, and predictors of unacceptable pain during the early stages of rheumatoid arthritis (RA), with and without low inflammation. The authors concluded that over a 5-year period, more than one-third of patients studied had unacceptable pain that was linked to lower swollen joints.

This study looked at the effectiveness selpercatinib (Retevmo) for the treatment of patients with RET fusion-positive non-small cell lung cancer (NSCLC) that has spread to the brain. The authors found that selpercatinib was effective in these patients. 

This study looked at the effect of high-intensity interval training (HIIT) after a stroke. It found that HIIT improved walking distance, balance, and some parts of brain function in the short term.  

This study looked at patients on triple therapy for blood pressure control. It found that taking fewer separate pills was associated with better blood pressure control.  

This study looked at which antiplatelet drug is better in patients who had percutaneous coronary intervention (PCI). It found that patients who had maintenance treatment with clopidogrel (Plavix) were less likely to suffer from a heart attack, bleeding, stroke, or death over the following 24 months compared to those treated with aspirin.